the us government yesterday approved the use of taxol a potential cancer fighter derived from the bark of pacific yew trees for ovarian cancer patients who have not responded to other treatments reuter reports from washington taxol is being studied for a number of other cancer uses including breast lung and head and neck cancers the new drug will be marketed by bristolmyers squibb